Reply to: CHAI and MACK-3 as noninvasive indices for nonalcoholic steatohepatitis
2019
Optimizing Use of Nonalcoholic Fatty Liver Disease Fibrosis Score, Fibrosis-4 Score, and Liver Stiffness Measurement to Identify Patients with Advanced Fibrosis.
2019
MACK-3 (Combination of hoMa, Ast, CK18): a promising novel biomarker for fibrotic non-alcoholic steatohepatitis
2019
Limited applicability of cathepsin D for the diagnosis and monitoring of non-alcoholic steatohepatitis
2019
Prescription of statin and treatment targets in non-alcoholic fatty liver disease patients.
2018
Current Therapies - What Has Promise? What Does Not?
2018
Comparing Shear Wave Elastography and Transient Elastography for the Diagnosis of Fibrosis Stages in Patients with Non-alcoholic Fatty Liver Disease Using Liver Biopsy as the Reference Standard
2018
Direct Acting Anti-Viral (DAA) in Hepatitis C Virus (HCV) Patients: Early Real-World Data From Malaysia.
